Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.130
+0.100 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.000
-0.130 (-4.15%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Xenetic Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 7 | 5 | 6 | 5 | 4 | 17 | |
| Market Cap Growth | 93.81% | -19.20% | 15.76% | 22.93% | -74.96% | -3.19% | |
| Enterprise Value | -1 | 1 | -1 | -4 | -10 | -2 | |
| Last Close Price | 3.13 | 2.17 | 3.99 | 3.45 | 2.85 | 12.90 | |
| PS Ratio | 2.41 | 1.67 | 2.46 | 2.09 | 2.53 | 14.88 | |
| PB Ratio | 0.97 | 0.67 | 1.02 | 0.54 | 0.32 | 0.94 | |
| P/TBV Ratio | 0.97 | 0.67 | 1.02 | 0.54 | 0.32 | 0.94 | |
| EV/Sales Ratio | - | 0.29 | - | - | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | - | - | - | 0.00 | |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.03 | -0.92 | -0.96 | -0.99 | |
| Net Debt / EBITDA Ratio | - | - | - | - | - | 3.17 | |
| Net Debt / FCF Ratio | 3.45 | 3.45 | 2.19 | 2.18 | 2.82 | 3.85 | |
| Asset Turnover | 0.39 | 0.39 | 0.29 | 0.20 | 0.10 | 0.07 | |
| Quick Ratio | 8.14 | 8.14 | 6.90 | 11.10 | 12.20 | 12.84 | |
| Current Ratio | 8.32 | 8.32 | 7.37 | 11.84 | 12.72 | 13.18 | |
| Return on Equity (ROE) | -40.00% | -40.00% | -50.12% | -35.27% | -40.90% | -36.88% | |
| Return on Assets (ROA) | -23.21% | -23.21% | -30.02% | -22.29% | -24.32% | -21.77% | |
| Return on Capital Employed (ROCE) | -38.30% | -38.30% | -70.00% | -46.10% | -49.20% | -31.20% | |
| Earnings Yield | -37.38% | -53.92% | -64.36% | -77.78% | -151.53% | -32.69% | |
| FCF Yield | -31.89% | -45.99% | -45.79% | -77.40% | -107.47% | -27.43% | |
| Buyback Yield / Dilution | -10.40% | -10.40% | -0.86% | -7.44% | -38.38% | -60.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.